BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16968820)

  • 1. Cytolytic cells induce HMGB1 release from melanoma cell lines.
    Ito N; DeMarco RA; Mailliard RB; Han J; Rabinowich H; Kalinski P; Stolz DB; Zeh HJ; Lotze MT
    J Leukoc Biol; 2007 Jan; 81(1):75-83. PubMed ID: 16968820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High mobility group box I (HMGB1) release from tumor cells after treatment: implications for development of targeted chemoimmunotherapy.
    Dong Xda E; Ito N; Lotze MT; Demarco RA; Popovic P; Shand SH; Watkins S; Winikoff S; Brown CK; Bartlett DL; Zeh HJ
    J Immunother; 2007 Sep; 30(6):596-606. PubMed ID: 17667523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacille-Calmette Guèrin induces caspase-independent cell death in urothelial carcinoma cells together with release of the necrosis-associated chemokine high molecular group box protein 1.
    See WA; Zhang G; Chen F; Cao Y; Langenstroer P; Sandlow J
    BJU Int; 2009 Jun; 103(12):1714-20. PubMed ID: 19154459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein induces high-mobility group box-1 protein release through activation of p38MAPK in macrophage RAW264.7 cells.
    Kawahara K; Biswas KK; Unoshima M; Ito T; Kikuchi K; Morimoto Y; Iwata M; Tancharoen S; Oyama Y; Takenouchi K; Nawa Y; Arimura N; Jie MX; Shrestha B; Miura N; Shimizu T; Mera K; Arimura S; Taniguchi N; Iwasaka H; Takao S; Hashiguchi T; Maruyama I
    Cardiovasc Pathol; 2008; 17(3):129-38. PubMed ID: 18402807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of the release of high-mobility group box 1 protein from dying cells during human immunodeficiency virus type 1 infection in vitro.
    Barqasho B; Nowak P; Abdurahman S; Walther-Jallow L; Sönnerborg A
    J Gen Virol; 2010 Jul; 91(Pt 7):1800-9. PubMed ID: 20200191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells prolong tumor-specific T-cell survival and effector function after interaction with tumor targets.
    Mailliard RB; Lotze MT
    Clin Cancer Res; 2001 Mar; 7(3 Suppl):980s-988s. PubMed ID: 11300500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMGB1-secreting capacity of multiple cell lineages revealed by a novel HMGB1 ELISPOT assay.
    Wähämaa H; Vallerskog T; Qin S; Lunderius C; LaRosa G; Andersson U; Harris HE
    J Leukoc Biol; 2007 Jan; 81(1):129-36. PubMed ID: 16980509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pivotal advance: inhibition of HMGB1 nuclear translocation as a mechanism for the anti-rheumatic effects of gold sodium thiomalate.
    Zetterström CK; Jiang W; Wähämaa H; Ostberg T; Aveberger AC; Schierbeck H; Lotze MT; Andersson U; Pisetsky DS; Erlandsson Harris H
    J Leukoc Biol; 2008 Jan; 83(1):31-8. PubMed ID: 17913975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMGB1 release in co-cultures of porcine endothelial and human T cells.
    Kawahara K; Setoyama K; Kikuchi K; Biswas KK; Kamimura R; Iwata M; Ito T; Morimoto Y; Hashiguchi T; Takao S; Maruyama I
    Xenotransplantation; 2007 Nov; 14(6):636-41. PubMed ID: 17991152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of human umbilical vein endothelial cells leads to relocation and release of high-mobility group box chromosomal protein 1.
    Mullins GE; Sunden-Cullberg J; Johansson AS; Rouhiainen A; Erlandsson-Harris H; Yang H; Tracey KJ; Rauvala H; Palmblad J; Andersson J; Treutiger CJ
    Scand J Immunol; 2004 Dec; 60(6):566-73. PubMed ID: 15584967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of hyperthermia in addition to ionizing irradiation fosters necrotic cell death and HMGB1 release of colorectal tumor cells.
    Schildkopf P; Frey B; Mantel F; Ott OJ; Weiss EM; Sieber R; Janko C; Sauer R; Fietkau R; Gaipl US
    Biochem Biophys Res Commun; 2010 Jan; 391(1):1014-20. PubMed ID: 19968962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of organophosphorus pesticide-induced inhibition of cytolytic activity of killer cells.
    Li Q; Kawada T
    Cell Mol Immunol; 2006 Jun; 3(3):171-8. PubMed ID: 16893497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
    Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethyl pyruvate induces necrosis-to-apoptosis switch and inhibits high mobility group box protein 1 release in A549 lung adenocarcinoma cells.
    Lim SC; Choi JE; Kim CH; Duong HQ; Jeong GA; Kang HS; Han SI
    Int J Mol Med; 2007 Aug; 20(2):187-92. PubMed ID: 17611636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of lymphokine-activated killer cells generation in vitro by soluble factors released from mixed human tumor and peripheral blood mononuclear adherent cells culture.
    Eisenthal A; Barbarsteyn E; Gitstein G; Lifschitz-Mercer B
    Cancer Invest; 2006 Feb; 24(1):28-34. PubMed ID: 16466989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-mobility group box 1 protein induces HIV-1 expression from persistently infected cells.
    Thierry S; Gozlan J; Jaulmes A; Boniface R; Nasreddine N; Strauss F; Maréchal V
    AIDS; 2007 Jan; 21(3):283-92. PubMed ID: 17255735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased susceptibility to immune destruction of B16BL6 tumor cells engineered to express a novel pro-Smac fusion protein.
    Rüttinger D; Li R; Poehlein CH; Haley D; Walker EB; Hu HM; Fox BA
    J Immunother; 2008 Jan; 31(1):43-51. PubMed ID: 18157011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes.
    Valenti R; Huber V; Filipazzi P; Pilla L; Sovena G; Villa A; Corbelli A; Fais S; Parmiani G; Rivoltini L
    Cancer Res; 2006 Sep; 66(18):9290-8. PubMed ID: 16982774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral cancer cell lines can use multiple ligands, including Fas-L, TRAIL and TNF-alpha, to induce apoptosis in Jurkat T cells: possible mechanisms for immune escape by head and neck cancers.
    Kassouf N; Thornhill MH
    Oral Oncol; 2008 Jul; 44(7):672-82. PubMed ID: 17996489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterial infection induces the secretion of high-mobility group box 1 protein.
    Grover A; Taylor J; Troudt J; Keyser A; Sommersted K; Schenkel A; Izzo AA
    Cell Microbiol; 2008 Jun; 10(6):1390-404. PubMed ID: 18331466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.